Search Results - "antiviral"

Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection by Omotayo O. Oyedara, Joseph M. Agbedahunsi, Folasade M. Adeyemi, Alfredo Juárez-Saldivar, Olatomide A. Fadare, Charles O. Adetunji, Gildardo Rivera

Connect to this object online.

In Silico Strategies for Prospective Drug Repositionings

DOAB: download the publication
DOAB: description of the publication

In Silico Strategies for Prospective Drug Repositionings

DOAB: download the publication
DOAB: description of the publication

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis by Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ

Connect to this object online.

Cardiac Involvement in COVID-19 Patients: A Contemporary Review by Domenico Maria Carretta, Aline Maria Silva, Donato D'Agostino, Skender Topi, Roberto Lovero, Ioannis Alexandros Charitos, Angelika Elzbieta Wegierska, Monica Montagnani, Luigi Santacroce

Connect to this object online.

"We usually see a lot of delay in terms of coming for or seeking care": an expert consultation on COVID testing and care pathways in seven low- and middle-income countries by Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N. Chifamba, Titus Divala, Andres G. Lescano, Mohammed Majam, Danjuma Mbo, Auliya A. Suwantika, Marco A. Tovar, Pragya Yadav, Elisabeth L. Corbett, Anna Vassall, Mark Jit

Connect to this object online.

Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and mo... by Shahkaar Aziz, Muhammad Waqas, Tapan Kumar Mohanta, Sobia Ahsan Halim, Aqib Iqbal, Amjad Ali, Asaad Khalid, Ashraf N. Abdalla, Ajmal Khan, Ahmed Al-Harrasi

Connect to this object online.

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023 by Mojca Maticic, J. Cernosa, C. Loboda, J. Tamse, R. Rigoni, E. Duffell, I. Indave, R. Zimmermann, L. Darragh, J. Moura, A. Leicht, T. Windelinckx, M. Jauffret-Roustide, K. Schiffer, T. Tammi

Connect to this object online.

Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients by Carla Marina Román-Montes, Carla Marina Román-Montes, Yesenia Flores-Soto, Guillermo Arturo Guaracha-Basañez, Karla María Tamez-Torres, José Sifuentes-Osornio, Ma. Fernanda González-Lara, Alfredo Ponce de León

Connect to this object online.

Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status by Gonçalo Matias, Robert Taylor, François Haguinet, Cynthia Schuck-Paim, Roger Lustig, Vivek Shinde

Connect to this object online.

Independent inhibition of the polymerase and deubiquitinase activities of the Crimean-Congo Hemorrhagic Fever Virus full-length L-protein. by Egor P Tchesnokov, Ben A Bailey-Elkin, Brian L Mark, Matthias Götte

Connect to this object online.

COVID-19 mortality sentinel surveillance at a tertiary referral hospital in Lusaka, Zambia, 2020-2021. by Jonas Z Hines, Priscilla Kapombe, Adam Mucheleng'anga, Stephen L Chanda, Amos Hamukale, Mweene Cheelo, Kashala Kamalonga, Leigh Tally, Mwaka Monze, Muzala Kapina, Simon Agolory, Andrew F Auld, Patrick Lungu, Roma Chilengi

Connect to this object online.

Patterns and trends of hepatitis C virus infection in Jordan: an observational study by Issa Abu-Dayyeh, Hiam Chemaitelly, Hiam Chemaitelly, Hiam Chemaitelly, Mohammad Ghunaim, Thaer Hasan, Amid Abdelnour, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad

Connect to this object online.

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries by M. Maticic, Z. Pirnat, A. Leicht, R. Zimmermann, T. Windelinck, M. Jauffret-Roustide, E. Duffell, T. Tammi, E. Schatz

Connect to this object online.

Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19 by Dimple Patel, Christopher Mccoy, Kendall Donohoe, Matthew Lee, Howard Gold, Ryan Chapin

Connect to this object online.

Treatment as prevention for hepatitis C virus in the Middle East and North Africa: a modeling study by Houssein H. Ayoub, Sarwat Mahmud, Sarwat Mahmud, Hiam Chemaitelly, Hiam Chemaitelly, Hiam Chemaitelly, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad, Laith J. Abu-Raddad

Connect to this object online.

A learning health system approach to the COVID‐19 pandemic: System‐wide changes in clinical practice and 30‐day mortality among hospitalized patients by Erin K. McCreary, Kevin E. Kip, J. Ryan Bariola, Mark Schmidhofer, Tami Minnier, Katelyn Mayak, Debbie Albin, Jessica Daley, Kelsey Linstrum, Erik Hernandez, Rachel Sackrowitz, Kailey Hughes, Christopher Horvat, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, David T. Huang, Derek C. Angus, Oscar C. Marroquin

Connect to this object online.

Estimating disease burden of a potential A(H7N9) pandemic influenza outbreak in the United States by Walter Silva, Tapas K. Das, Ricardo Izurieta

Connect to this object online.

TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis. by Bethany Brunton, Kai Rogers, Elisabeth K Phillips, Rachel B Brouillette, Ruayda Bouls, Noah S Butler, Wendy Maury

Connect to this object online.

Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness by Nalinikanta Rajkumar, Lokeshwar Singh Khumukcham, Dhabali Thangjam, Surender Singh, Giten Khwairakpam, Sonjelle Shilton, Amit Goel

Connect to this object online.